Indivior, which develops long-acting injectable treatments for opioid use disorder (OUD), has consolidated creative, media, and digital responsibilities with Havas. McKinney previously handled creative and Click Health oversaw media and digital, according to sources familiar with the account.
Havas will lead integrated strategy, creative, media, and digital efforts across both healthcare professional (HCP) and direct-to-consumer (DTC) audiences. The account will be managed across Havas Life New York, Havas Media Network, and Havas CX under a single P&L, with Chris Schnurman, managing director of Havas Life New York, serving as executive sponsor.
COMvergence estimates Indivior’s 2025 U.S. media spend at $60 million.
Havas previously worked with Indivior through its consumer health group Jacques NY (formerly Havas Tonic) before the account moved to McKinney in 2023. The revenue from this expanded partnership is “totally incremental,” said Schnurman, and marks a return to the roster with a broader remit.
The new agency model follows leadership change at Indivior, including the appointment of CEO Joe Ciaffoni, as it refocuses on growing its long-acting injectable treatments in a category marked by stigma, regulation, and complicated patient journeys.
“People with opioid use disorder are very difficult to find. Their mindset and their readiness to take on treatment changes on a daily basis,” Schnurman said. “Finding these people at the right time with the right message and getting them connected to the right physician requires a whole lot of coordination.”
For Havas, the assignment reflects an ongoing effort to operate integrated creative, media, and experience teams. The holding company created its village model in 2017, bringing Havas Creative and Havas Media under a single P&L, and in 2022 merged Havas Creative with Havas Health under CEO Donna Murphy.
“Indivior didn’t come to us for an advertising solution; they came to us for integration,” Greg James, CEO of Havas Media Network North America, told ADWEEK.
He added that while the key goal is to drive more effective work, efficiencies are to be gained as well. “You generally will see efficiencies and cost savings because there’s less duplication,” he said.
